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Abstract
Purpose We evaluated the diagnostic accuracy of magnetic resonance imaging (MRI) for 46 consecutive patients
with lipomatous soft tissue tumors prior to biopsy and resection. Twenty-eight patients had benign lipomas and 18 had
liposarcomas. Clinical differences between thdse patients with benign disease and those with malignant lesions were
average age at the time of presentation (49 years for benign vs 62 years for malignant, p < 0.001) and average length of
symptoms prior to resection (64 months for benign versus 38 months for malignant, p= 0.01). MRI characteristics
associated with benign disease included: smaller tumor size (9.4 cm average greatest dimension for benign lesions vs
13.4 cm for malignant masses, p=0.022); a mass with a uniformly homogeneous signal (p= 0.0003); a mass with
homogeneous high T1 and T2 signals and a low short-time-inversion-recovery (STIR) signal comparable to normal fat
(p< 0.0001). This last signal pattern was not seen in malignant lesions (0/18) and was present in almost all benign lipomas
(25/28). The usual MRI descriptions of soft tissue masses such as infiltrating vs encapsulating, deep vs subcutaneous and
septated vs non-septated were not helpful predictors of malignancy in this series. Needle biopsies of lipomatous masses
with heterogeneous signals on MRI resulted in inaccurate diagnoses due to sampling error in 5/9 patients.
Discussion. A carefully planned and performed MRI study of lipomatous masses can accurately predict a benign lipoma
whenever a homogeneous high T1 and T2, as well as a low STIR, signal is present. However, a mass with any other signal
characteristics must be biopsied carefully in order to make an accurate diagnosis.
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Introduction
Magnetic resonance imaging (MRI) has greatly
enhanced our ability to analyze the anatomical rela-
tionships and some internal characteristics of soft
tissue masses. MRI of extremity soft tissue masses
can show tissue contrast and tumor margins that are
superior to images obtained with other modalities
(i.e. computed tomography, ultrasound or angiogra-
phy).
1-4 Therefore, MRI is frequently the imaging
procedure of choice for the evaluation of soft tissue
neoplasms. Unfortunately, many large soft tissue
tumors have indistinct (MRI) characteristics and the
MRI cannot determine whether the tumour is
benign or malignant. 5’6.
Normal fat tissue has a characteristic MRI
appearance. Fat has a high signal on T1-weighted
images, a high signal on T2-weighted images and a
low signal on short-time-inversion-recovery (STIR)
images.%7 Furthermore, the appearance of the subja-
cent subcutaneous fat acts as a control for the
presence or absence of normal fat within a lipoma-
tous tumor. It is a deviation in appearance from
normal fat that raises a concern about the benign
nature of a lipomatous tumor. This relationship
remains constant regardless of pulse sequence or
imaging parameters. Because every patient has nor-
mal subcutaneous fat tissue, each MRI study has an
’internal control’ for comparison with a suspected
soft tissue mass. Sarcomatous tissue usually has
non-fatty elements which are represented by a lower
T1, higher T2 and a higher STIR signal than the
surrounding normal subcutaneous fat. Most other
non-fatty soft tissue neoplasms (benign and malig-
nant) have these same MRI characteristics making
this a very non-specific pattern.
Benign lipomas represent the most common soft
tissue mass
8 and liposarcomas are the second most
common soft tissue malignancy in adults.9 Because
the surgical management of these lesions varies
greatly depending on the histological diagnosis, it is
helpful to define the MRI characteristics of benign
and malignant lipomatous masses. We chose to
evaluate the clinical features at the time of referral,
the predictive value of the MRI signal characteris-
tics, and the biopsy results in patients with benign
benign and malignant lipomatous masses treated at
our institution.
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Patients and methods
Forty-six consecutive patients with lipomatous soft
tissue masses were evaluated in a blind fashion over
a 3-year period using MRI prior to biopsy and
excision. These MRI studies were examined by one
co-author (MD) who was blind to the diagnosis and
was not involved in the care of the patents. Data
were tabulated for the anatomic location, size and
depth of the mass. The size of the mass was
recorded in centimeters to describe length, width
and height. The overall largest dimension for the
mass was used for size analysis. Depth of the mass
was scored as subcutaneous, intermuscular or intra-
muscular. Each lesion was also characterized as
either encapsulated or infiltrating, and it was noted
whether septations were present within the lesion.
Every patient underwent a complete study of their
lesion that involved multiple plane analysis with
T1-weighted and T2-weighted sequences. Twenty-
seven of the 46 patients also underwent a STIR
sequence. For clinical imaging of soft tissue masses,
STIR sequences are selected resulting in nulling of
the signal from fat within the image. These STIR
images, which are closely related to the conventional
spin echo sequences, are widely used in muscu-
loskeletal applications.
7
All MRI studies were assessed for the signal
intensity of the mass based on T1-weighted, T2-
weighted and STIR images, along with the signal
intensity of the mass compared to uninvolved sub-
cutaneous fat on T1-weighted, T2-weighted and
STIR images. Each category was recorded as high,
intermediate or low signal. When compared to
subcutaneous fat, masses were scored as greater
than, less than or equal to the signal intensity of the
subcutaneous fat surrounding the mass. Each mass
was also described as having a homogeneous or
heterogeneous signal. Following initial clinical
evaluations and radiographic analysis, a needle,
incisional or excisional biopsy was performed at the
discretion of BTR.
All biopsy material and resected specimens were
evaluated by the senior author and a faculty member
of the pathology department. The final diagnosis
was based on a thorough pathologic study of the
entire specimen.
Results
Clinical findings
Of the 46 patients with lipomatous masses (Table
1), there were 24 males and 22 females with an
average age of 54 years (range 29-87 years). There
was a total of 28 benign and 18 malignant lipoma-
tous masses. The duration of symptoms prior to
referral averaged 54 months (range 1-240 months).
The masses were located in the upper extremity in
13 patients and in the lower extremity in 27
patients. Three masses were paraspinous and three
others were flank masses. The average age of
patients with a benign mass at the time of treatment
was lower than that of patients with liposarcomas
(49 years, range 29-75 years, as compared to 62
years, range 48-87 years). This represented a statis-
tical difference (p < 0.001). The average duration of
symptoms prior to referral for patients with benign
disease was 64.1 months which was longer than for
the malignant group (38.0 months, p- 0.010).
MRI findings
Several standard MRI descriptive terms were
assessed to test whether they were predictive of
malignant vs benign lipomatous masses. Of the 46
masses (Table 2), 30 were described as encapsu-
lated and 16 infiltrating. Twenty-one lipomas were
described as encapsulated and seven were infil-
Table 1. Clinical differences of 46 patients with benign and
malignant lipomatous masses
Parameter Benign Malignant
Number of masses 28 18
Male 14 10
Female 14 8
Average age (years) 49 62
Length of symptoms (months) 64 38
The clinical information of46 patients who were studied
using MRI followed by biopsy and complete excision is
depicted in table format comparing data of benign vs
malignant lesions. The average age was the age at the time
of treatment. The length of symptoms was the patient’s
report of how long they were aware of the mass prior to
treatment.
Table 2. MRI anatomic characteristics of 46 lipomatous
masses
Parameter Benign Malignant Significance
Number of patients 28
Depth
Subcutaneous 10
Intramuscular 13
Intermuscular 5
Size (cm)
Encapsulated 21
Infiltrating 7
Homogeneous 25
Heterogeneous 3
Septated 13
9.4
18
2
11
5
13.4
p 0.064
p 0.002
p= 0.082
7 p 0.0003
11
8 p= 0.895
The traditional MRI anatomic characteristics for 46
patients with lipomatous masses are depicted in table format
and compared as benign vs malignant lesions. The size data
were recorded from the MRI in three dimensions but only
the average ofthe largest dimension (in cm) is reported here.MRI appearance of lipomatous masses 177
Table 3. MRI signal characteristics comparing benign vs malignant lesions
Parameter Benign Malignant Statistics
Homogenous: high T1, high T2, low STIR
Heterogenous: T1, T2, STIR
Homogenous: low T1, high T2, high STIR
25/28 0/18 p< 0.001
3/28 11/18 p < 0.001
0/28 7/18 p < 0.001
Three patterns of MRI signal characteristic are reported in table format to show the
differences between benign and malignant lesions.
trating as compared to nine encapsulated liposarco-
mas and nine infiltrating. Evidence of encapsulation
vs infiltration on the MRI was not predictive of
tumor grade (p 0.082). Twenty-four of the masses
were described as intramuscular, ten intermuscular
and twelve subcutaneous. MRI characteristics of
compartmentalization of the mass did not help to
distinguish between benign and malignant lesions
(p 0.130). Masses that were deep to the muscle
fascia were malignant in 16/34 cases and subcuta-
neous lesions were malignant in 2/12 cases. Depth
of the lesion was also not strongly predictive of
malignancy (p=0.064). Twenty-one of the 46
masses had septations. Thirteen of the 28 benign
masses were found to have septations vs 8/18
liposarcomas; this offered no clinical help
(p 0.895).
Liposarcomas tended to be larger than benign
lipomas on MRI imaging. The average measure-
ment of the largest dimension of the benign mass
was 9.4 cm (range 4-21 cm) and 13.4 cm (range
3-24 cm) for patients with liposarcomas
(p 0.022).
Certain MRI signal characteristics were studied
for their predictive potential for liposarcomas vs
lipomas (see Figs 1-3). Homogeneous high T1 and
T2 and low STIR MRI signal characteristics were
present in all 25 benign lipomas. Of the remaining
21 masses that did not have these characteristics, 18
were malignant (Table 3). This was highly statisti-
cally significant (p < 0.001). The three patients who
had benign masses, yet had a heterogeneous signal
simulating a malignancy, were spindle cell variant of
a benign lipoma, a fibrolipoma and a recurrent
atypical lipoma.
on MRI were also identified on histologic evaluation
of the benign lipomas. These linear strands
appeared to be normal vessels and fibrous bands. It
was difficult to tell whether the fibrous bands were
produced by the tumors or were portions of normal
fascia that had been incorporated into the mass as it
grew, displacing the surrounding muscle and neu-
rovascular structures. Soft tissue masses are more
difficult than bone lesions to carry out exact MRI to
pathologic mapping, since soft tissue lesions change
shape with manipulation. However, areas of dedif-
ferentiation and other grossly observable changes
within the masses could be correlated with the MRI
studies.
Although not a primary focus of this research, we
evaluated the accuracy of limited biopsy samples
compared to the final diagnosis based on the entire
specimen. There was a total of nine needle biopsies
of which five were incorrectly diagnosed histologi-
cally. Of these five, one benign lesion was diagnosed
as an atypical lipoma from needle biopsy with a final
pathology diagnosis of spindle cell lipoma. Four
malignant lesions were misdiagnosed by needle
biopsy. Three of these had erroneous benign diag-
noses that were corrected after an incisional biopsy
and later resection. The fourth biopsy was erro-
neously interpreted as low-grade malignancy when
in fact the lesion contained areas of high-grade
dedifferentiation. This problem of inaccurate lim-
ited biopsies occurred only in patients with masses
that had heterogeneous signals on MRI, strongly
suggesting that sampling errors had occurred. Inci-
sional biopsies were performed in seven of these
patients and were correctly interpreted in all of
them.
Pathologic findings
The final pathologic diagnosis was benign lipoma in
28 patients which consisted of 15 intramuscular
lipomas, 10 subcutaneous lipomas, one deep
fibrolipoma, one spindle cell lipoma and one
benign, deep atypical lipoma. Of the liposarcomas
(18 masses), there were four myxoid, four dediffer-
entiated, two pleomorphic, four well differentiated,
one round cell and three low-grade liposarcomas.
Careful study of the benign lipomas revealed no
evidence of primative lipoblasts or frank malignant
features. However, the linear strands that were seen
Discussion
Certain clinical clues have traditionally been used to
aid in the diagnosis between benign and malignant
soft tissue masses. Malignant soft tissue masses are
typically larger than 5 cm, are located deep to the
muscle fascia, have a short history of rapid enlarge-
ment and have an infiltrating or poorly encapsulated
appearance on radiographic images.
8 Unfortunately,
none of these characteristics was universally predic-
tive of malignancy in our series. We found that even
benign lipomas can become quite large, comparable
to liposarcomas, although liposarcomas do tend to178 B. T. Rougraff et al.
Fig. 1. (a) ‘4 65-year-oldpatientpresented with a large, deep buttock mass that is seen here on a Tl-weighted, coronalMRI study.
There is a large mass which is deep to the gluteus maximus musclefascia and has a tissue signal which is mostly equivalent to the normal
subcutaneous fat. However, the mass extends into the greater sciaticforamen and, in this region, the mass has a dark T1 signal very
differentfrom normalfat. (b) The same patient with an axial cut T2-weighted image that shows a high signal intensity differentfrom
the rest ofthe lesion. (c) The same patient studied with a coronalSTIR sequence in the same plane as the T1 shown in Fig. 1 (a). Here
the segment of the tumor within the sciatic notch is clearly ofhigher signal intensity than normalfat. The pathologic evaluation of this
area revealed a high-grade, dedifferentiated liposarcoma.
Fig. 2. (a) A Tl-weighted axialMRI study ofa 42-year-oldfemale with a slowly enlarging mass on her thigh. The T1 image shows
a large, deep, high-signal mass with septations that completely encases the femur. (b) This T2-weighted image shows similarfindings
as the axial T1 images seen in Fig. 2(a). The mass is similar to the subcutaneousfat with the exception ofthe septations that are present.
(c) A sagital STIR image of the same lesion. This image shows a very dark and homogeneous signal mass that is equivalent to
subcutaneous fat and darker than normal muscle. Note that the septations seen on T1 are not bright on STIR. Thorough pathologic
evaluation revealed a benign lipoma without evidence of atypia. She underwent a marginal excision and is disease free 2 years after
excision. MRI predicts that this is a benign lipoma because of the homogeneous signal, particularly on STIR sequences.
Fig. 3. (a) ,4 Tl-weighted axial image of a 50-year-old man with a rapidly enlarging subcutaneous mass. The TI signal is
heterogeneous, but mostly equivalent in characteristics to the surroundingfat. (b) ,4 T2-weightedimage ofthe same lesion showing similar
signal characteristics to fat, exceptfor a small eccentric region ofhigh signal. (c) ,4 STIR study of the same lesion showing significant
areas ofhigh intensity that is very differentfrom the surroundingfat. This difference is most obvious on this STIR sequence. The lesion
was biopsied and excised and the pathologic diagnosis was benign, spindle cell lipoma. This heterogeneous presentation is similar to how
a liposarcoma could appear. MRI cannot make this determination when there is a heterogeneous signal present.be larger on average. Likewise, we have shown that
for lipomatous masses, depth is not always a reliable
indicator of malignancy. Septations and encapsula-
tion of lipomatous masses were also poor indicators
of malignancy with 50% of the liposarcomas show-
ing encapsulation and 46% of the benign lipomas
having septations.
We have shown that certain MRI signal character-
istics are very accurate at diagnosing benign lipo-
mas. The sensitivity in predicting a benign lipoma
was 89% and specificity reached 100% in this study.
The positive predictive value was 100% for all 25
patients with a homogeneous high T1, high T2 and
low STIR signal (comparable to normal fat). All of
the homogeneous masses with low T1, high T2 and
high STIR signals (contrasting with normal fat)
were malignant. However, this latter MRI pattern is
not diagnostic of liposarcomas since large neurilem-
momas, neurofibromas, myxomas and other types of
soft tissue benign and malignant neoplasms can
have this MRI appearance.
9-11 A biopsy would be
necessary to diagnose a mass with this MRI pattern
accurately. The third MRI pattern of heterogeneous
signals represents a diagnostic problem. Although
most of these masses were liposarcomas (11/14
patients), needle biopsies misdiagnosed the lesions
more than half of the time due to sampling errors of
the heterogeneous mass. This would have resulted
in undertreatment of four liposarcomas in this series
of patients if incisional biopsies had not been per-
formed prior to resection.
In conclusion, if the MRI study completely
images the mass in multiple planes, using thin cuts
and with T1, T2 and STIR sequences, and the mass
has a homogeneous signal comparable to normal fat
(high T1, high T2 and low STIR), the surgeon can
assume that this is a benign lipoma. Observation of
the patient without a biopsy is supported by our
findings. A complete excision without contami-
nation of the pseudo-capsule of this lesion would be
indicated if the lesion is sufficiently symptomatic.
However, if a patient has a mass with a heteroge-
neous MRI characteristic signal, the lesion is likely
to represent a liposarcoma. A needle biopsy of a
heterogeneous mass interpreted as benign should
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then undergo an incisional biopsy by a surgeon who
is experienced in oncologic surgery because a sam-
pling error may have occurred. If a biopsy is to be
performed of a mass with a heterogeneous signal, a
sample of an area of the mass with low T1, high T2
and high STIR should be obtained for the most
accurate diagnosis. If the mass has a homogeneous
signal that does not compare to fat on any sequence,
MRI can only predict that it is not a typical benign
lipoma. This pattern can be seen with sarcomas as
well as several types of benign masses. Treatment of
these lesions should be based on an accurate biopsy.
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